在严重疾病病例增加后，美国食品药品监督管理局暂停了所有婴儿呼吸道合胞病毒疫苗试验。 - Suppr

Suppr

超能文献

FDA pauses all infant RSV vaccine trials after rise in severe illnesses.

作者信息

Mahase Elisabeth

机构信息

The BMJ.

出版信息

BMJ. 2024 Dec 23;387:q2852. doi: 10.1136/bmj.q2852.

DOI:10.1136/bmj.q2852

PMID:39725458

Abstract

摘要

相似文献

FDA pauses all infant RSV vaccine trials after rise in severe illnesses.在严重疾病病例增加后，美国食品药品监督管理局暂停了所有婴儿呼吸道合胞病毒疫苗试验。

BMJ. 2024 Dec 23;387:q2852. doi: 10.1136/bmj.q2852.

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.含稳定温度敏感性突变的活呼吸道合胞病毒（RSV）疫苗候选物在 RSV 血清阴性婴儿和儿童中高度减毒。

J Infect Dis. 2018 Apr 11;217(9):1338-1346. doi: 10.1093/infdis/jiy066.

Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines.呼吸道合胞病毒疫苗的研发、现状及尚存挑战

Vaccines (Basel). 2025 Jan 21;13(2):97. doi: 10.3390/vaccines13020097.

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.疫苗和相关生物制品咨询委员会会议摘要，会议旨在评估预防 RSV -naive 婴儿呼吸道合胞病毒病的候选疫苗。

Vaccine. 2020 Jan 10;38(2):101-106. doi: 10.1016/j.vaccine.2019.10.048. Epub 2019 Nov 6.

Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.呼吸道合胞病毒疫苗研发中的挑战与机遇：美国食品药品监督管理局/美国国立卫生研究院研讨会会议报告

Vaccine. 2016 Sep 22;34(41):4843-4849. doi: 10.1016/j.vaccine.2016.07.057. Epub 2016 Aug 25.

Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study.老年人用呼吸道合胞病毒预融合 F 疫苗进行再接种的安全性和免疫原性：一项 2b 期研究。

J Infect Dis. 2024 Feb 14;229(2):355-366. doi: 10.1093/infdis/jiad321.

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.一项针对年龄大于或等于65岁成年人的，含和不含磷酸铝佐剂的A亚组呼吸道合胞病毒亚单位疫苗的剂量范围研究。

Vaccine. 2009 Sep 25;27(42):5913-9. doi: 10.1016/j.vaccine.2009.07.038. Epub 2009 Aug 3.

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.活减毒呼吸道合胞病毒疫苗候选物，缺失 RNA 合成调节蛋白 M2-2，在儿童中具有高度免疫原性。

J Infect Dis. 2018 Apr 11;217(9):1347-1355. doi: 10.1093/infdis/jiy040.

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.一种减毒活呼吸道合胞病毒疫苗在5至24月龄健康的呼吸道合胞病毒血清阴性儿童中的安全性和免疫原性。

PLoS One. 2013 Oct 29;8(10):e77104. doi: 10.1371/journal.pone.0077104. eCollection 2013.

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection.抗呼吸道合胞病毒（RSV）PFP疫苗的安全性和免疫原性：蛋白质印迹分析有助于区分PFP疫苗与RSV感染的免疫反应。

Vaccine. 1995 Aug;13(12):1095-101. doi: 10.1016/0264-410x(95)00034-x.

引用本文的文献

Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor.候选的呼吸道合胞病毒（RSV）黏膜双价疫苗Metavac-RSV可保护棉鼠免受肺病毒感染，并且是在生物反应器中使用无血清细胞培养生产的。

NPJ Vaccines. 2025 Aug 22;10(1):202. doi: 10.1038/s41541-025-01231-9.

Beyond the first breath: comprehensive respiratory syncytial virus prevention through maternal immunization and infant immunoprophylaxis.初呼吸之外：通过母体免疫和婴儿免疫预防实现呼吸道合胞病毒的全面防控

Asian Biomed (Res Rev News). 2025 Jul 28;19(3):116-130. doi: 10.2478/abm-2025-0015. eCollection 2025 Jun.

Challenges and Limitations of Current RSV Prevention Strategies in Infants and Young Children: A Narrative Review.当前婴幼儿呼吸道合胞病毒预防策略的挑战与局限：一项叙述性综述

Vaccines (Basel). 2025 Jul 1;13(7):717. doi: 10.3390/vaccines13070717.

An Update on Prevention of Paediatric Respiratory Syncytial Virus Hospitalizations in Canada.加拿大预防小儿呼吸道合胞病毒住院治疗的最新情况

J Assoc Med Microbiol Infect Dis Can. 2025 Mar 26;10(1):2-5. doi: 10.3138/jammi-2025-0203. eCollection 2025 Mar.

mRNA Vaccine Technology Beyond COVID-19.新冠疫情之后的mRNA疫苗技术

Vaccines (Basel). 2025 May 31;13(6):601. doi: 10.3390/vaccines13060601.

Pharmacological mechanisms of probenecid for SARS-CoV-2 and RSV co-infection: findings of system pharmacology, molecular docking, molecular dynamics simulation, and structure-activity relationship.丙磺舒治疗新型冠状病毒肺炎和呼吸道合胞病毒合并感染的药理机制：系统药理学、分子对接、分子动力学模拟及构效关系研究结果

Front Microbiol. 2025 Apr 30;16:1552603. doi: 10.3389/fmicb.2025.1552603. eCollection 2025.

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progress.推进用于传染病的信使核糖核酸疫苗：关键组成部分、创新与临床进展

Essays Biochem. 2025 May 1;69(2):EBC20253009. doi: 10.1042/EBC20253009.

Vaccination in pregnancy to protect the newborn.孕期接种疫苗以保护新生儿。

Nat Rev Immunol. 2025 Apr 23. doi: 10.1038/s41577-025-01162-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验